The TP53 mutation, R337H, is associated with Li-Fraumeniand Li-Fraumeni-like syndromes in Brazilian families

Achatz, Maria Isabel Waddington; Olivier, Magali; Le Calvez, Florence; Martel Planche, Ghyslaine; Lopes, Ademar; Rossi, Benedito Mauro; Ashton-Prolla, Patricia; Giugliani, Roberto; Palmero, Edenir Inez; Vargas, Fernando Regla; Rocha, Jos‚ Claudio Casali da; Vettore, Andre Luiz; Hainaut, Pierre.
Cancer Lett ; 245(1-2): 96-102, Jan.8, 2007. ilus, tab
Artículo en Inglés | TXTC | ID: txt-24646

Documentos relacionados

  1. [Update on Li-Fraumeni syndrome].
  2. An updated quantitative model to classify missense variants in the TP53 gene: A novel multifactorial strategy.
  3. Common activities and predictive gene signature identified for genetic hypomorphs of <i>TP53</i>.
  4. The evaluation of the possibility of Li-Fraumeni syndrome in cancer patients in East Azarbaijan Province of Iran.
  5. Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni Syndrome.
  6. Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome.
  7. [A rhabdomyosarcoma patient from a Li-Fraumeni syndrome family: a case report and literature review].
  8. First case of endometrial cancer after yolk sac tumor in a patient with Li-Fraumeni syndrome.
  9. Misdiagnosis of Li-Fraumeni Syndrome in a Patient With Clonal Hematopoiesis and a Somatic <i>TP53</i> Mutation.
  10. A first report of a rare TP53 variant associated with Li-Fraumeni syndrome manifesting as invasive breast cancer and malignant solitary fibrous tumor.